Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children. A multicentric double-blind vs placebo study;Prevenzione della diarrea associata ad antibiotici con Lactobacillus sporogenes e frutto-oligosaccaridi. Studio pediatrico multicentrico in doppio cieco vs placebo

Minerva Pediatrica

Volumn 55, Issue 5, 2003, Pages 447-452

  La Rosa, M ^a   Bottaro, G ^b   Gulino, N ^b   Gambuzza, F ^b   Di Forti, F ^b   Ini G ^b   Tornambe E ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE

Author keywords

Antibiotics; Child; Diarrhea; Probiotics

Indexed keywords

AMOXICILLIN; CEPHALOSPORIN; CLAVULANIC ACID; ERYTHROMYCIN; MACROLIDE;

ARTICLE; CHILD; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; EVALUATION; FEMALE; FOLLOW UP; HUMAN; LACTOBACILLUS; LACTOBACILLUS SPOROGENES; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; LACTOBACILLUS; MALE; OLIGOSACCHARIDES; PLACEBOS; PROBIOTICS;

EID: 0344873256     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Barbut F, Meynard JL. Managing antibiotic associated diarrhoea. Probiotics may help in prevention. BMJ 2002;324:1345-6.
2. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002;324:1361-7.
3. Periti P. Il lievito Saccharomyces boulardii nella prevenzione e trattamento delle diarree infantili. Farmac Terap 2002:12:61-71.
4. Gotz V, Romankiewicz JA, Moss J, Murraj HW. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 1979;36:754-7.
5. Saxelin M. Lactobacillus GG. A human probiotic strain with through clinical documentation. Food Rev Int 1997;13:293-313.
6. Caropreso E. I microorganismi probiotici: effetti sul trattamento e sulla prevenzione delle diarree acute. Aggiorn Pediatr 1998;1:81-5.
7. Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic Agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 1996;275:870-6.
8. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989;66:365-78.
9. Miniello VL, Brunetti L, Granieri L, Tarantino M, Armenio L. Prebiotici e probiotici: ruolo in immuno-allergologia. Atti IV Congresso Nazionale Società Italiana di Allergologia ed Immunologia Pediatrica. Firenze 29-31 maggio 2001.
10. Pacchetti B. Lactospore@ (Lactobacillus s.) a sporiferous preparation of bacilli and a new turning for probiotic. Gastroenterol Int 1998;11:144-5.
11. Bondi M, Messi P, Marchioretto DI. Caratteristiche di LABLYS98, un Lactobacillus sporogenes da impiegarsi in preparati probiotici. Ind Alim 2000;39:704-10.
12. Gandhi AB. Lactobacillus sporogene an advancement in Lactobacillus therapy. East Pharm 1988;8:41-4.
13. Tomomatsu H. Health effects of oligosaccharides. Food Technol 1994;10:61-5.
14. Hidaka H, Eida T, Takizawa T, Tokunaga T, Tashiro Y. Effects of fructooligosaccharides on intestinal flora and human health. Bifidobacteria Microflora 1986;5:37-50.
15. Le nuove frontiere della nutrizione: i prebiotici. Med Paz 1999;3:34.